CLINICAL_TRIALS
trial_result
· 2018-10-26
Clinical Trial Update: Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients [Phase 3]
Summary
Phase 3 randomized, double-blind trial evaluating tolerability of RBP-7000 in patients with schizophrenia; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-26